Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

JNJ - JOHNSON & JOHNSON


148.15
0.510   0.344%

Share volume: 11,027,059
Last Updated: Tue 21 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.31%

PREVIOUS CLOSE
CHG
CHG%

$147.64
1.12
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
59%
Profitability 79%
Dept financing 36%
Liquidity 69%
Performance 43%
Company vs Stock growth
vs
Performance
5 Days
0.76%
1 Month
1.98%
3 Months
-9.36%
6 Months
-3.95%
1 Year
-8.81%
2 Year
-11.98%
Key data
Stock price
$148.15
P/E Ratio 
26.46
DAY RANGE
$147.05 - $148.86
EPS 
$15.42
52 WEEK RANGE
$140.68 - $168.85
52 WEEK CHANGE
-$6.80
MARKET CAP 
388.529 B
YIELD 
3.01%
SHARES OUTSTANDING 
2.407 B
DIVIDEND
$1.24
EX-DIVIDEND DATE
08/27/2024
NEXT EARNINGS DATE
N/A
BETA 
0.09
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$9,542,802
AVERAGE 30 VOLUME 
$7,762,657
Company detail
CEO: Joaquin Duato
Region: US
Website: jnj.com
Employees: 152,700
IPO year: 1970
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.

Recent news